Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium
about
Vaccines against invasive Salmonella disease: current status and future directionsUsing monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugateNew knowledge on pathogenesis of bacterial enteric infections as applied to vaccine developmentCorrelation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technologyPreparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar TyphimuriumSalmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella DiseaseGlycoconjugate vaccine strategies for protection against invasive Salmonella infections.Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays.Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain.Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.Clonal analysis of primary B cells responsive to the pathogenic bacterium Salmonella typhimurium.Monoclonal antibodies to outer membrane antigens of Vibrio cholerae.Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.Characterization of murine antibody response to Salmonella typhimurium by a class-specific solid-phase radioimmunoassayProtection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.Protective ability of antibodies against 78- and 40-kilodalton outer membrane antigens of Haemophilus somnusEffectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in miceProtection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.Immunoglobulin M and immunoglobulin G responses in BALB/c mice to conjugated outer membrane extracts of four Salmonella serotypesCoprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibodyPathogenesis and immunity in murine salmonellosisSerum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa.Isotype of protective anti-Salmonella antibodies in experimental mouse salmonellosisInduction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharide-protein conjugatesImmunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis.Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.The human intestinal IgA response; burning questions.
P2860
Q27007088-367A8F2F-370C-4524-9953-BE38321BD9A9Q33542433-6C0A611F-3A87-4388-AA5A-7A816070C458Q33579987-5600D99F-06A6-4C8B-9A8D-BC272E2067EAQ33617144-C1B4B5EF-F413-4B90-8CDC-8F40D7814E71Q33628356-921C2807-593F-4FBB-B3D7-DCE1A5423FDAQ33899161-2E2200E5-294B-4CD6-9873-CCE28022CF44Q34044935-6FB8D10C-513D-4ED5-9F97-F64074327439Q34714055-6285E3A7-8365-486C-B60C-9DD435CD42E2Q34760675-5E20C4FF-042F-4D72-9E5C-6726E160199EQ35098175-63CC1A0B-61B8-4756-85BC-C0CB42B79F8BQ35272921-E8E3B5D3-CC62-41B1-AE24-4B1C7D737B62Q35887055-AC2DE03E-338F-46D0-8529-69324AE100C7Q35964671-736EDE56-1C62-47AB-BD03-9B30A078278FQ36131886-D3066A93-38E0-4079-90CB-0C04D81B8989Q36184367-B3A30F10-1A24-416B-A2AC-62FDF8A1E3BBQ36331669-E4D9BBB9-1673-406B-A263-8EABB7B49063Q36331701-D260F774-0472-45A6-9D22-731B86F887A7Q36335391-8DB40014-77E9-4123-92AC-AF62AC9AA85DQ36353323-B1D432AE-D9A3-4F5D-97A5-BBE27E7C8780Q36435458-C4A43538-34CD-4263-B813-B2AD954CC129Q36446367-C674691D-17A2-43F5-8A92-09E42DBB206BQ36446401-8510C49B-3B94-4D06-A034-030EC5F5A5E8Q36453873-5C85D4AB-3763-4BEE-A127-28C2E8EB8734Q36970577-B13909E3-4D98-4508-B462-C4A7D9A6FD29Q36998805-09732303-6B71-4E23-B69D-57A43C8D834EQ36998840-7D48D314-D61B-45B5-8789-8C707D9ACCA4Q37000487-84CA729A-A32A-4864-9A28-E9F8DE0FF20FQ37000969-3F37CA77-EF0C-4FD3-AF54-83720245CBBBQ37011770-09F1F9B0-076B-447D-A7E3-BFD0481DA240Q37017494-ADA0F80F-9503-476D-97D1-BE03AA8C9AE5Q37032900-46E0ABCB-D9D5-4C42-AD0F-EDC0F698D093Q37034449-593C55C4-59F5-4A9F-978D-AB2BE9A53592Q37055869-07DA5C9D-3853-43E3-84BB-7C874FC7D6C1Q37078483-7871DC4D-3E48-41B0-A524-8BC9410E9238Q37079645-C4EBDFE9-3A9E-4139-9351-2E449BC3F86CQ37085231-EA1985EC-2F19-4713-80C0-5C6078D28166Q37104718-453B9D38-CAC9-4625-99C8-61235D482417Q37667270-579ADCF7-11B0-4897-945B-92DB0A4F2B0AQ37880344-3F422E18-11EC-4897-9BF4-FEC5C6147709Q38010705-EB774075-7D76-4169-9712-A64EC949D017
P2860
Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium
description
1979 nî lūn-bûn
@nan
1979 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@ast
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@en
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@nl
type
label
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@ast
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@en
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@nl
prefLabel
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@ast
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@en
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@nl
P2093
P2860
P1476
Artificial Salmonella vaccines ...... on with Salmonella typhimurium
@en
P2093
Lindberg AA
Nurminen M
Svenson SB
P2860
P304
P407
P577
1979-09-01T00:00:00Z